The Effectiveness of Trastuzumab Combined with Sequential Chemotherapy for Metastatic Gastric Carcinoma with Overexpression of HER2

Publisher： Karger

E-ISSN： 1662-6575|10|2|644-648

ISSN： 1662-6575

Source： Case Reports in Oncology, Vol.10, Iss.2, 2017-07, pp. : 644-648

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Combination of Trastuzumab and Triple FLOT Chemotherapy (5-Fluorouracil/Leucovorin, Oxaliplatin, and Docetaxel) in Patients with HER2-Positive Metastatic Gastric Cancer: Report of 3 Cases

By  

Oncology Research and Treatment, Vol. 35, Iss. 9, 2012-08 ,pp. : 505-508

Karger

Access to resources Recommend Favorite

Positive Response to Trastuzumab in a Case of HER2-Overexpressing Metastatic Gastric Cancer that Presented as Severe Thrombocytopenia

By  

Oncology Research and Treatment, Vol. 34, Iss. 11, 2011-10 ,pp. : 621-624

Karger

Access to resources Recommend Favorite

Trastuzumab plus Chemotherapy in Gastric Cancer Overexpressing HER-2 and EGFR: A Case Report

By  

Oncology Research and Treatment, Vol. 34, Iss. 1-2, 2011-01 ,pp. : 42-45

Karger

Access to resources Recommend Favorite

Durable Response of Human Epidermal Growth Factor Receptor-2-Positive Gastric Adenosquamous Carcinoma to Trastuzumab-Based Chemotherapy

By  

Case Reports in Oncology, Vol. 7, Iss. 1, 2014-03 ,pp. : 210-216

Karger

Access to resources Recommend Favorite

Successful Treatment of a Patient with HER2-Positive Metastatic Gastric Cancer with Third-Line Combination Therapy with Irinotecan, 5-Fluorouracil, Leucovorin and Trastuzumab (FOLFIRI-T)

By  

Oncology Research and Treatment, Vol. 34, Iss. 10, 2011-09 ,pp. : 548-551

Karger

Access to resources Recommend Favorite